235 related articles for article (PubMed ID: 22522852)
1. [Hereditary angioedema. A therapeutic guide].
Malbrán A; Fernández Romero DS; Menéndez A
Medicina (B Aires); 2012; 72(2):119-23. PubMed ID: 22522852
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary angioedema. Treatment of acute attacks in Argentina].
Malbrán A; Malbrán E; Menéndez A; Fernández Romero DS
Medicina (B Aires); 2014; 74(3):198-200. PubMed ID: 24918666
[TBL] [Abstract][Full Text] [Related]
3. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
4. Current treatment of hereditary angioedema: An update on clinical studies.
Banerji A
Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
6. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
7. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
Bork K
Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
[TBL] [Abstract][Full Text] [Related]
8. New treatment options for acute edema attacks caused by hereditary angioedema.
Thomas MC; Shah S
Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
[TBL] [Abstract][Full Text] [Related]
9. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
Bernstein JA; Moellman JJ
Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.
Cicardi M; Bork K; Caballero T; Craig T; Li HH; Longhurst H; Reshef A; Zuraw B;
Allergy; 2012 Feb; 67(2):147-57. PubMed ID: 22126399
[TBL] [Abstract][Full Text] [Related]
11. [Allergy-immunology. New therapies for acute attacks in hereditary angioedema].
Leimgruber A
Rev Med Suisse; 2011 Jan; 7(278):103-5. PubMed ID: 21400938
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary angioedema--treatment].
Muszyńska A; Fal AM
Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
[TBL] [Abstract][Full Text] [Related]
13. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
Bernstein JA
Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
[TBL] [Abstract][Full Text] [Related]
14. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
16. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary angioedema: new mechanisms and therapeutic options].
Reshef A; Leibovich I; Goren A; Kidon M
Harefuah; 2009 Aug; 148(8):529-34, 571. PubMed ID: 19899257
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in management and treatment of hereditary angioedema.
Sardana N; Craig TJ
Pediatrics; 2011 Dec; 128(6):1173-80. PubMed ID: 22065270
[TBL] [Abstract][Full Text] [Related]
19. Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States.
Tachdjian R; Johnson KE; Casso D; Oliveria SA; Devercelli G; Jain G
Allergy Asthma Proc; 2020 May; 41(3):172-182. PubMed ID: 32375961
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
